bioRxiv · 10.1101/2020.09.17.301523
High-sensitivity vision restoration via ectopic expression of chimeric rhodopsin in mice
Abstract
Photoreception requires amplification by mammalian rhodopsin through G protein activation, which requires a visual cycle. To achieve this in retinal gene therapy, we incorporated human rhodopsin cytoplasmic loops into Gloeobacter rhodopsin, thereby generating Gloeobacter and human chimeric rhodopsin (GHCR). In a murine model of inherited retinal degeneration, we induced retinal GHCR expression by intravitreal injection of a recombinant adeno-associated virus vector. Retinal explant and visual thalamus electrophysiological recordings, behavioral tests, and histological analysis showed that GHCR restored dim-environment vision and prevented the progression of retinal degeneration. Thus, GHCR may be a potent clinical tool for the treatment of retinal disorders. One Sentence SummaryOptogenetic therapy with Gloeobacter and human chimeric rhodopsin resulted in highly sensitive visual restoration and protection effects.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Katada, Y., Yoshida, K., Kobayashi, K., Hideyuki, O., Kandori, H., Tsubota, K., Kurihara, T.. 2020-09-18. High-sensitivity vision restoration via ectopic expression of chimeric rhodopsin in mice. https://doi.org/10.1101/2020.09.17.301523
Cite the original work for its findings. Save a collection to share your selection of sources.